Gyre Therapeutics
A majority-owned Beijing unit sells China's pirfenidone lung-fibrosis therapy while San Diego runs the antifibrotic pipeline.
$6.59
After-hours close−0.01 (−0.15%)
At close$6.60(−1.20%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 7.94%8.85M sharesInsiders 5.46%6.09M sharesOther 86.60%96.55M shares
Shares outstanding 111.49M · Float 32.86M · 29.5% free float
Institutions13F, as of Jun 30, 2026
62 holders · 8.85M shares · 15 new positions · 46 increased · 8 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| SC China Holding Ltd | 3.75M | 3.36% | +3.75Mnew | Aug 13, 2026 |
| BlackRock, Inc. | 993.9K | 0.89% | +235.3K | Aug 7, 2026 |
| Octagon Capital Advisors LP | 954.4K | 0.86% | +954.4Knew | Aug 14, 2026 |
| Vanguard Capital Management LLC | 876.9K | 0.79% | −107.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 533.0K | 0.48% | +101.5K | Aug 12, 2026 |
| State Street Corp | 245.4K | 0.22% | +29.1K | Aug 7, 2026 |
| Charles Schwab Investment Management Inc | 184.3K | 0.17% | +19.0K | Aug 14, 2026 |
| Sixth Street Partners Management Company, L.P. | 184.3K | 0.17% | +184.3Knew | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| GNI USA, Inc.incl. GNI Group Ltd. | 69.10% | 86.32M | 13D | May 6, 2026 ↗ |
| Ping Lanincl. Ying Luo | 8.60% | 10.21M | 13D | May 6, 2026 ↗ |
| Ying Luo (“Mr. Luo”)incl. Ping Lan | 8.54% | 8.46M | 13D | Sep 6, 2024 ↗ |
| Songjiang Ma (“Mr. Ma”)incl. Yueying Zhu | 7.62% | 7.46M | 13D | Sep 6, 2024 ↗ |
| Songjiang Maincl. Yueying Zhu | 6.33% | 7.34M | 13D | May 7, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Songjiang Ma | director, officer: President | 2.81M | 2.52% | May 29, 2025 |
| Ying Luo | director, officer: Chief Executive Officer | 2.57M | 2.30% | May 7, 2026 |
| Weiguo Ye | officer: Chief Operating Officer | 700.0K | 0.63% | Jun 22, 2026 |
| Thomas Wilson Eastling | director | 15.0K | 0.01% | Apr 18, 2025 |
1 ten-percent owner holds 64.01M shares by Form 4, outside the officers-and-directors figure above · 1 person has not refiled in the last 18 months (1.6K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 18, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 3,000 | $6.35 | 700,000 |
| Jun 10, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale · 2 lots | 11,418 | $6.22 | 700,000 |
| Jun 9, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale · 2 lots | 17,500 | $6.14 | 700,000 |
| Jun 11, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 2,800 | $6.17 | 700,000 |
| Jun 4, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 19,575 | $6.13 | 700,000 |
| Jun 5, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 15,401 | $6.40 | 700,000 |
| May 26, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 4,000 | $6.10 | 700,000 |
| May 22, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 3,500 | $6.08 | 700,000 |
| May 21, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 12,820 | $6.15 | 700,000 |
| May 19, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 9,120 | $6.37 | 700,000 |
CongressHouse and Senate disclosures
Not reported.